List of Excipients in API cocaine hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing cocaine hydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Genus Lifesciences Inc | GOPRELTO | cocaine hydrochloride | 64950-359 | ANHYDROUS CITRIC ACID | 2037-02-07 |
| Genus Lifesciences Inc | GOPRELTO | cocaine hydrochloride | 64950-359 | D&C YELLOW NO. 10 | 2037-02-07 |
| Genus Lifesciences Inc | GOPRELTO | cocaine hydrochloride | 64950-359 | FD&C GREEN NO. 3 | 2037-02-07 |
| Genus Lifesciences Inc | GOPRELTO | cocaine hydrochloride | 64950-359 | SODIUM BENZOATE | 2037-02-07 |
| Genus Lifesciences Inc | GOPRELTO | cocaine hydrochloride | 64950-359 | WATER | 2037-02-07 |
| Genus Lifesciences Inc | COCAINE HYDROCHLORIDE | cocaine hydrochloride | 64950-362 | ANHYDROUS CITRIC ACID | 2037-02-07 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for cocaine hydrochloride
Excipient focus: ANHYDROUS CITRIC ACID
cocaine hydrochloride drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Genus Lifesciences Inc | cocaine hydrochloride | 64950-359 |
| Genus Lifesciences Inc | cocaine hydrochloride | 64950-362 |
| LXO US INC | cocaine hydrochloride | 70839-362 |
| >Company | >Ingredient | >NDC |
cocaine hydrochloride drug variants not containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | cocaine hydrochloride nasal | 0527-1961 |
| Lannett Company Inc | cocaine hydrochloride nasal | 0527-1971 |
| OMNIVIUM PHARMACEUTICALS LLC | cocaine hydrochloride nasal | 81665-300 |
| OMNIVIUM PHARMACEUTICALS LLC | cocaine hydrochloride nasal | 81665-301 |
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID MONOHYDRATE
cocaine hydrochloride drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | cocaine hydrochloride nasal | 0527-1961 |
| Lannett Company Inc | cocaine hydrochloride nasal | 0527-1971 |
| OMNIVIUM PHARMACEUTICALS LLC | cocaine hydrochloride nasal | 81665-300 |
| OMNIVIUM PHARMACEUTICALS LLC | cocaine hydrochloride nasal | 81665-301 |
| >Company | >Ingredient | >NDC |
cocaine hydrochloride drug variants not containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Genus Lifesciences Inc | cocaine hydrochloride | 64950-359 |
| Genus Lifesciences Inc | cocaine hydrochloride | 64950-362 |
| LXO US INC | cocaine hydrochloride | 70839-362 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
cocaine hydrochloride drug variants containing D&C YELLOW NO. 10
cocaine hydrochloride drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C GREEN NO. 3
cocaine hydrochloride drug variants containing FD&C GREEN NO. 3
cocaine hydrochloride drug variants not containing FD&C GREEN NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BENZOATE
cocaine hydrochloride drug variants containing SODIUM BENZOATE
cocaine hydrochloride drug variants not containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
cocaine hydrochloride drug variants containing WATER
cocaine hydrochloride drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
